top of page
A framework to support new product introduction in national health systems
Resource Library


Pediatric DRV/r (pDRV/r) FAQs
This document is meant to answer some of the most common questions that surround pediatric darunavir/ritonavir 120/20mg (pDRV/r) - a new...
Sep 6, 2023
Â
Â


Pediatric DRV/r (pDRV/r) Product Profile
This product profile provides a clinical overview of the best-in-class protease inhibitor (PI) formulated in a fixed-dose combination...
Sep 6, 2023
Â
Â


Pediatric ALD (pALD) FAQs
This document is meant to answer some of the most common questions surround the fixed-dose combination of pediatric...
Jun 5, 2023
Â
Â


pALD Product Profile
This product profile provides a clinical overview of the fixed-dose combination of pediatric abacavir/lamivudine/ dolutegravir 60/30/5 mg...
May 30, 2023
Â
Â


CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
Mar 17, 2022
Â
Â


CHAI Pediatric DTG Product Profile
This product profile provides a clinical overview of pediatric DTG, market updates and implementation considerations, and provides...
Oct 12, 2021
Â
Â


TLD Resources
CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
Aug 1, 2018
Â
Â


CHAI TLD Product Profile
This presentation provides a broad overview of the benefits of DTG-containing regimens, the advantages of fixed-dose combination ARVs,...
Aug 1, 2017
Â
Â


CHAI Pediatric LPV/r Oral Pellets Product Profile
This presentation provides a broad overview of pediatric LPV/r oral pellets, guidance on administration, and key considerations for...
Jan 1, 2017
Â
Â
bottom of page